Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease

被引:303
作者
Norris, JM
Barriga, K
Hoffenberg, EJ
Taki, I
Miao, DM
Haas, JE
Emery, LM
Sokol, RJ
Erlich, HA
Eisenbarth, GS
Rewers, M
机构
[1] Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA
[2] Univ Colorado, Dept Pathol, Denver, CO 80262 USA
[3] Hlth Sci Ctr, Denver, CO 80262 USA
[4] Univ Colorado, Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Denver, CO 80262 USA
[5] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
[6] Roche Mol Syst Inc, Dept Human Genet, Alameda, CA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 19期
关键词
D O I
10.1001/jama.293.19.2343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context While gluten ingestion is responsible for the signs and symptoms of celiac disease, it is not known what factors are associated with initial appearance of the disease. Objective To examine whether the timing of gluten exposure in the infant diet was associated with the development of celiac disease autoimmunity (CDA). Design, Setting, and Patients Prospective observational study conducted in Denver, Colo, from 1994-2004 of 1560 children at increased risk for celiac disease or type 1 diabetes, as defined by possession of either HLA-DR3 or DR4 alleles, or having a first-degree relative with type 1 diabetes. The mean follow-up was 4.8 years. Main Outcome Measure Risk of CDA defined as being positive for tissue transglutaminase (tTG) autoantibody on 2 or more consecutive visits or being positive for tTG once and having a positive small bowel biopsy for celiac disease, by timing of introduction of gluten-containing foods into the diet Results Fifty-one children developed CDA. Findings adjusted for HLA-DR3 status indicated that children exposed to foods containing wheat, barley, or rye (gluten-containing foods) in the first 3 months of life Q [6%] CDA positive vs 40 [3%] CDA negative) had a 5-fold increased risk of CDA compared with children exposed to gluten-containing foods at 4 to 6 months (12 [23%] CDA positive vs 574 [38%) CDA negative) (hazard ratio [HR], 5.17; 95% confidence interval [CI], 1.44-18.57). Children not exposed to gluten until the seventh month or later (36 [71%] CDA positive vs 895 [59%] CDA negative) had a marginally increased risk of CDA compared with those exposed at 4 to 6 months (HR, 1.87; 95% Cl, 0.97-3.60). After restricting our case group to only the 25 CDA-positive children who had biopsy-diagnosed celiac disease, initial exposure to wheat, barley, or rye in the first 3 months Q [12%] CDA positive vs 40 [3%] CDA negative) or in the seventh month or later (19 [76%] CDA positive vs 912 [59%] CDA negative) significantly increased risk of CDA compared with exposure at 4 to 6 months (3 [12%] CDA positive vs 583 [38%] CDA negative) (HR, 22.97; 95% Cl, 4,55-115.93; P=.001; and HR, 3.98; 95% Cl, 1.18-13.46; P=.04, respectively). Conclusion Timing of introduction of gluten into the infant diet is associated with the appearance of CDA in children at increased risk for the disease.
引用
收藏
页码:2343 / 2351
页数:9
相关论文
共 38 条
[1]  
Allison P., 1995, SURVIVAL ANAL USING
[2]   Influence of infant feeding and gluten intake on coeliac disease [J].
Ascher, H ;
Krantz, I ;
Rydberg, L ;
Nordin, P ;
Kristiansson, B .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (02) :113-117
[3]   DOES BREAST-FEEDING PROTECT AGAINST THE DEVELOPMENT OF CLINICAL SYMPTOMS OF CELIAC-DISEASE IN CHILDREN [J].
AURICCHIO, S ;
FOLLO, D ;
DERITIS, G ;
GIUNTA, A ;
MARZORATI, D ;
PRAMPOLINI, L ;
ANSALDI, N ;
LEVI, P ;
DALLOLIO, D ;
BOSSI, A ;
CORTINOVIS, I ;
MARUBINI, E .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1983, 2 (03) :428-433
[4]   Development of a novel rapid non-invasive screening test for coeliac disease [J].
Baldas, V ;
Tommasini, A ;
Trevisiol, C ;
Berti, I ;
Fasano, A ;
Sblattero, D ;
Bradbury, A ;
Marzari, R ;
Barillari, G ;
Ventura, A ;
Not, T .
GUT, 2000, 47 (05) :628-631
[5]   One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies [J].
Bao, F ;
Yu, LP ;
Babu, S ;
Wang, TB ;
Hoffenberg, EJ ;
Rewers, M ;
Eisenbarth, GS .
JOURNAL OF AUTOIMMUNITY, 1999, 13 (01) :143-148
[6]  
Bonamico M, 2001, AM J GASTROENTEROL, V96, P1536
[7]   Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function [J].
Clemente, MG ;
De Virgiliis, S ;
Kang, JS ;
Macatagney, R ;
Musu, MP ;
Di Pierro, MR ;
Drago, S ;
Congia, M ;
Fasano, A .
GUT, 2003, 52 (02) :218-223
[8]   Endocrinological disorders and celiac disease [J].
Collin, P ;
Kaukinen, K ;
Välimäki, M ;
Salmi, J .
ENDOCRINE REVIEWS, 2002, 23 (04) :464-483
[9]   Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis [J].
Dieterich, W ;
Laag, E ;
Bruckner-Tuderman, L ;
Reunala, T ;
Kárpáti, S ;
Zágoni, T ;
Riecken, EO ;
Schuppan, D .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (01) :133-136
[10]   Identification of tissue transglutaminase as the autoantigen of celiac disease [J].
Dieterich, W ;
Ehnis, T ;
Bauer, M ;
Donner, P ;
Volta, U ;
Riecken, EO ;
Schuppan, D .
NATURE MEDICINE, 1997, 3 (07) :797-801